Stocksigma LogoStocksigma Logo

Bio Medica Laboratories Reports H1 FY27 Financial Results

Bio Medica Laboratories reported standalone revenue from operations of ₹1,668.64 lakhs for the half year ended 30th Sep'26, down 9.31% YoY from ₹1,839.90

Bio Medica Laboratories Reports H1 FY27 Financial Results

Bio Medica Laboratories Ltd · Financial Result · 13 Nov 2026, 11:55 pm

Bio Medica Laboratories Reports H1 FY27 Financial Results Bio Medica Laboratories reported standalone revenue from operations of ₹1,668.64 lakhs for the half year ended 30th Sep'26, down 9.31% YoY from ₹1,839.90 lakhs in the corresponding period ended 30th Sep'25. Standalone net profit declined 45.53% YoY to ₹283.81 lakhs from ₹521.01 lakhs, with basic and diluted EPS contracting to ₹2.26 from ₹5.68. On a consolidated basis, revenue stood at ₹2,160.78 lakhs with a net profit of ₹312.54 lakhs. The company operated with negative cash flows from operations of ₹997.71 lakhs.

Original exchange filing (PDF)

More announcements from Bio Medica Laboratories Ltd

All Bio Medica Laboratories Ltd announcements